查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547802

全球麻风病治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Leprosy Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 231 Pages | 商品交期: 最快1-2个工作天内

价格

全球麻风病治疗市场需求预计将从 2023 年的 32.8 亿美元达到 2032 年近 43.3 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 3.14%。

麻风病治疗是一种多药疗法，用于治疗慢性和进行性细菌感染麻风病，也称为汉森氏病。麻风病的特征是皮肤溃疡、神经损伤和肌肉无力等症状，导致严重毁容和严重残疾。皮肤切片检查可诊断不同类型的麻风病。治疗方法包括利福平、氨苯砜、氯法齐明和米诺环素等药物组合的多药物治疗(MDT)，疗程为六个月至两年，取决于疾病的类型及其临床严重程度。早期诊断、全面的抗菌疗程以及麻风反应的及时治疗使得几乎所有麻风病病例都可以完全治癒。此疗法涉及轻微的副作用，可能会导致社交和情绪困扰。

市场动态

全球麻风病患者人数的不断增加以及新治疗方案的出现将成为该市场成长的主要动力。透过活动提高意识、改善诊断和新技术的出现将进一步推动市场成长。政府组织的更多措施、高成本 MDT 治疗的报销政策的可用性将成为市场的助推器。改善医疗保健系统和医疗设施将有利于市场成长。该市场成长的主要障碍是由于社会经济条件不佳而造成的医疗保健普及率低和诊断效率低。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球麻风病治疗市场的每个细分市场进行了包容性评估。麻风病治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

麻风病治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按药物类别

  • 抗菌
  • 痲疯病
  • 抗结核药
  • 其他的

依给药途径

  • 口服
  • 可注射
  • 专题

按配销通路

  • 医院药房
  • 零售药局
  • 药局
  • 网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲麻风病治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。痲疯病治疗市场的主要参与者包括辉瑞公司、百时美施贵宝公司、礼来公司、强生服务公司、葛兰素史克公司、拜耳公司、卡迪拉製药公司、赛诺菲公司、诺华公司、梯瓦製药工业公司有限公司、Macleods Pharmaceuticals、默克公司。产品发布和其他开发。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：麻风病治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按药品类别分類的市场吸引力分析
    • 按给药途径进行的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球麻风病治疗市场分析：依药物类别

  • 按药物类别概述
  • 历史和预测数据
  • 按药物类别分析
  • 抗菌
  • 痲疯病
  • 抗结核药
  • 其他的

第 6 章：全球麻风病治疗市场分析：依给药途径

  • 依给药途径概述
  • 历史和预测数据
  • 依给药途径分析
  • 口服
  • 可注射
  • 专题

第 7 章：全球麻风病治疗市场分析：按分销管道

  • 配销通路概览
  • 历史和预测数据
  • 按配销通路分析
  • 医院药房
  • 零售药局
  • 药局
  • 网路药局

第 8 章：全球麻风病治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：痲疯病治疗公司的竞争格局

  • 麻风病治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bristol-Myers Squibb And Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Eli Lily And Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Johnson & Johnson Services Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GlaxoSmithKline PLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bayer AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cadila Pharmaceuticals
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sanofi SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Teva Pharmaceutical Industries Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Macleods Pharmaceuticals
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11213312

The global demand for Leprosy Treatment Market is presumed to reach the market size of nearly USD 4.33 Billion by 2032 from USD 3.28 Billion in 2023 with a CAGR of 3.14% under the study period 2024-2032.

Leprosy treatment is a multidrug therapy used to treat the chronic and progressive bacterial infection leprosy, also called Hansen's disease. Leprosy is characterized by symptoms like skin ulcers, nerve damage, and muscle weakness leading to severe disfigurement and significant disability. A skin biopsy diagnoses the different types of leprosy. The treatment involves a multidrug therapy (MDT) with a combination of drugs like rifampicin, dapsone, clofazimine, and minocycline for a period ranging from six months to two years, based on the type of the disease and its clinical severity. Early diagnosis and full anti-microbial courses and prompt treatment of leprosy reactions make a complete cure possible in almost every case of leprosy. The therapy involves minor side effects that can cause social and emotional distress.

MARKET DYNAMICS

The expanding pool of the global population suffering from leprosy and the availability of new treatment options will be the major driving forces for this market's growth. Raising awareness through campaigns, improved diagnosis, and the emergence of new technologies will further propel market growth. The increased initiatives by government organizations, availability of reimbursement policies for high-cost MDT therapies will be a market booster. Improving healthcare systems and medical facilities will be a boon to the market growth. The major roadblocks to this market's growth are low healthcare penetration and inefficient diagnosis due to poor socio-economic conditions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Leprosy Treatment. The growth and trends of Leprosy Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Leprosy Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

  • Antibacterial
  • Leprostatics
  • Antitubercular
  • Others

By Route of Administration

  • Oral
  • Injectable
  • Topical

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Leprosy Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Leprosy Treatment market include Pfizer Inc., Bristol-Myers Squibb And Company, Eli Lily And Company, Johnson & Johnson Services Inc., GlaxoSmithKline PLC, Bayer AG, Cadila Pharmaceuticals, Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals, Merck & Co. Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. LEPROSY TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Drug Class
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY DRUG CLASS

  • 5.1. Overview By Drug Class
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Drug Class
  • 5.4. Antibacterial Historic and Forecast Sales By Regions
  • 5.5. Leprostatics Historic and Forecast Sales By Regions
  • 5.6. Antitubercular Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Route of Administration
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. Injectable Historic and Forecast Sales By Regions
  • 6.6. Topical Historic and Forecast Sales By Regions

7. GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Distribution Channel
  • 7.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.6. Drug Stores Historic and Forecast Sales By Regions
  • 7.7. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE LEPROSY TREATMENT COMPANIES

  • 9.1. Leprosy Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF LEPROSY TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pfizer Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Bristol-Myers Squibb And Company
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Eli Lily And Company
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Johnson & Johnson Services Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. GlaxoSmithKline PLC
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Bayer AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Cadila Pharmaceuticals
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Sanofi S.A.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Novartis AG
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Teva Pharmaceutical Industries Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Macleods Pharmaceuticals
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Merck & Co. Inc
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Drug Class (Units and USD MN)
  • Antibacterial Market Sales By Geography (Units and USD MN)
  • Leprostatics Market Sales By Geography (Units and USD MN)
  • Antitubercular Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Analysis By Route of Administration (Units and USD MN)
  • Oral Market Sales By Geography (Units and USD MN)
  • Injectable Market Sales By Geography (Units and USD MN)
  • Topical Market Sales By Geography (Units and USD MN)
  • Analysis By Distribution Channel (Units and USD MN)
  • Hospital Pharmacies Market Sales By Geography (Units and USD MN)
  • Retail Pharmacies Market Sales By Geography (Units and USD MN)
  • Drug Stores Market Sales By Geography (Units and USD MN)
  • Online Pharmacies Market Sales By Geography (Units and USD MN)
  • Global Leprosy Treatment Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Leprosy Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Leprosy Treatment Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Drug Class (Units and USD MN)
  • Antibacterial Market Sales By Geography (Units and USD MN)
  • Leprostatics Market Sales By Geography (Units and USD MN)
  • Antitubercular Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Route of Administration (Units and USD MN)
  • Oral Market Sales By Geography (Units and USD MN)
  • Injectable Market Sales By Geography (Units and USD MN)
  • Topical Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Distribution Channel (Units and USD MN)
  • Hospital Pharmacies Market Sales By Geography (Units and USD MN)
  • Retail Pharmacies Market Sales By Geography (Units and USD MN)
  • Drug Stores Market Sales By Geography (Units and USD MN)
  • Online Pharmacies Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.